Literature DB >> 15526985

Selection of embryos for day-3 transfer at the pronuclear-stage and pronuclear-stage cryopreservation results in high delivery rates in fresh and frozen cycles.

Diane G Hammitt1, Christopher A Sattler, Misty L Manes, Anita P Singh.   

Abstract

PURPOSE: Evaluate IVF-ET outcome data for a unique culture and cryopreservation strategy.
METHODS: Retrospective study of 92 patients. Embryos for day-3 transfer were selected at pronuclear-stage; all extra zygotes were cryopreserved at pronuclear-stage.
RESULTS: Delivery rates for Anonymous Oocyte Donation (Group I), patients <35 years (Group II), and 35-38 years (Group III) were 52.9%, 61.5%, and 51.7% for fresh and 38.5%, 33.3%, and 40.0% for frozen transfer. Deliveries per retrieval were 82.3%, 71.8%, and 58.6%. Only 0.88, 0.80, and 0.61 more zygotes were cultured than what were used for fresh transfer. Singleton, twin, and triplet rates were 64.6%, 31.2%, and 4.2% for fresh and 69.2%, 30.8%, and 0% for frozen.
CONCLUSIONS: Selection of day-3 transfer embryos at the pronuclear-stage and cryopreservation of extra zygotes results in high delivery rates in fresh and frozen cycles. This approach optimizes deliveries per retrieval and provides many patients with more than one pregnancy per retrieval.

Entities:  

Mesh:

Year:  2004        PMID: 15526985      PMCID: PMC3455180          DOI: 10.1023/b:jarg.0000042013.62311.b2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  37 in total

1.  Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology.

Authors:  J Tesarik; A M Junca; A Hazout; F X Aubriot; C Nathan; P Cohen-Bacrie; M Dumont-Hassan
Journal:  Hum Reprod       Date:  2000-06       Impact factor: 6.918

2.  Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations.

Authors:  A A Milki; M D Hinckley; J D Fisch; D Dasig; B Behr
Journal:  Fertil Steril       Date:  2000-01       Impact factor: 7.329

3.  Pronuclear stage cryopreservation after intracytoplasmic sperm injection and conventional IVF: implications for timing of the freeze.

Authors:  M A Damario; D G Hammitt; T M Galanits; D R Session; D A Dumesic
Journal:  Fertil Steril       Date:  1999-12       Impact factor: 7.329

4.  Predictive value of 72-hour blastomere cell number on blastocyst development and success of subsequent transfer based on the degree of blastocyst development.

Authors:  B S Shapiro; D C Harris; K S Richter
Journal:  Fertil Steril       Date:  2000-03       Impact factor: 7.329

5.  The number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer.

Authors:  C Racowsky; K V Jackson; N A Cekleniak; J H Fox; M D Hornstein; E S Ginsburg
Journal:  Fertil Steril       Date:  2000-03       Impact factor: 7.329

6.  Embryo cryopreservation at the pronuclear stage and efficient embryo use optimizes the chance for a liveborn infant from a single oocyte retrieval.

Authors:  M A Damario; D G Hammitt; D R Session; D A Dumesic
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

7.  The morphology of human pronuclear embryos is positively related to blastocyst development and implantation.

Authors:  L Scott; R Alvero; M Leondires; B Miller
Journal:  Hum Reprod       Date:  2000-11       Impact factor: 6.918

8.  Blastocyst quality affects the success of blastocyst-stage embryo transfer.

Authors:  B Balaban; B Urman; A Sertac; C Alatas; S Aksoy; R Mercan
Journal:  Fertil Steril       Date:  2000-08       Impact factor: 7.329

9.  Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: a prospective randomized clinical trial.

Authors:  J Gerris; D De Neubourg; K Mangelschots; E Van Royen; M Van de Meerssche; M Valkenburg
Journal:  Hum Reprod       Date:  1999-10       Impact factor: 6.918

10.  Day 5 versus day 3 embryo transfer: a controlled randomized trial.

Authors:  S Coskun; J Hollanders; S Al-Hassan; H Al-Sufyan; H Al-Mayman; K Jaroudi
Journal:  Hum Reprod       Date:  2000-09       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.